Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Post-stripping telangiectasis].

B Hutinel, M Maraval

    Phlebologie
    |October 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Post-operative telangiectasias, or spider veins, commonly appear on the thighs and knees within six months after saphenous vein stripping. Prevention involves minimally invasive techniques and consistent post-operative support, with treatment reserved for six months post-surgery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Synthesis of glycoconjugates by human diseased veins: modulation by procyanidolic oligomers.

    International journal of experimental pathology·1997
    Same author

    [Hyaluronic acid (hyaluronan) levels in pathological human saphenous veins. Effects of procyanidol oligomers].

    Pathologie-biologie·1997
    Same author

    [Surgery of essential varicose veins].

    La Revue du praticien·1994
    Same author

    Evaluation of different systems for clinical quantification of varicose veins.

    The Journal of dermatologic surgery and oncology·1991
    Same author

    [Varices and pregnancy].

    Journal des maladies vasculaires·1987
    Same author

    [Left predominance of varices: myth or reality?].

    Phlebologie·1986
    Same journal

    [Effect of veinotonyl 75 on the capillary permeability test using technetium albumin in cyclic orthostatic edemas].

    Phlebologie·1993
    Same journal

    [Variceal thromboses, their ambulatory treatment].

    Phlebologie·1993
    Same journal

    [Endoscopic treatment of perforating veins--current data].

    Phlebologie·1993
    Same journal

    [Program for the development and storing of images].

    Phlebologie·1993
    Same journal

    [Neutrophil activation in experimental venous hypertension].

    Phlebologie·1993
    Same journal

    [Is duplex echography mandatory in cases of deep venous insufficiency?].

    Phlebologie·1993
    See all related articles

    Area of Science:

    • Vascular Surgery
    • Phlebology
    • Dermatology

    Context:

    • Telangiectasias, commonly known as spider veins, can develop after saphenous vein stripping procedures.
    • Capillary fragility is a significant factor in the occurrence of these post-operative vascular changes.
    • The antero-internal and external thighs and knees are the most frequent sites for these developments.

    Purpose:

    • To identify the common causes and timing of post-operative telangiectasias following saphenous vein stripping.
    • To outline effective preventive strategies for minimizing the occurrence of these vascular lesions.
    • To recommend appropriate treatment timelines for managing established telangiectasias.

    Summary:

    • Post-operative telangiectasias typically manifest between one and six months after saphenous vein stripping, particularly in patients with capillary fragility.

    Related Experiment Videos

  • Unnecessary or overly aggressive stripping of saphenous veins is identified as a primary cause.
  • Prevention strategies include employing minimally traumatic stripping techniques, utilizing fine strippers, ensuring rigorous post-operative support, and wearing compression garments for 1-3 months.
  • Impact:

    • Highlights the importance of surgical technique in preventing post-operative telangiectasias.
    • Provides clear guidelines for patient management, including compression therapy duration.
    • Establishes a recommended waiting period of at least six months before initiating microsclerotherapy for treatment.